Signet cell cancer is a rare type of cancer that mostly starts in the glandular cells. It is also called signet ring cell cancer. Nearly 57 out of 100 (57%) of all signet cell cancers start in the ...

A team of scientists has developed new ways to better understand and treat signet ring cell carcinoma (SRCC), a rare form of colorectal cancer (CRC), which starts in the colon or rectum. SRCC, which ...

S, Principal Investigator at A*STAR SRL are co-authors of the study. While the current study focuses on basal cell carcinoma (BCC), researchers believe the technology could also be adapted to ...

Purpose: The global burden of colorectal cancer (CRC) continues to rise, with elderly populations disproportionately affected. Despite oxaliplatin’s established role in first-line metastatic CRC (mCRC ...

At this earliest stage, abnormal cells are found only in the innermost lining of the colon or ... to uncontrolled cell growth and proliferation, eventually resulting in cancer.

Colorectal cancer is rising among younger people, especially rectal cancer, with key warning signs including abdominal pain, diarrhea, blood in stool, and iron deficiency anemia. Early screening and a ...

Department of Clinical Pharmacology, The Second Hospital of Anhui Medical University, Hefei 230601, China Clinical Research Unit, Changhai Hospital, Naval Medical University, Shanghai 200433, China ...

Background: Breast and vulvar metastases from rectal signet ring cell carcinoma (SRCC) represent a rare and obscure ... targeted and immunotherapies for colorectal adenocarcinoma on SRCC, so novel ...